Continuous intrathecal baclofen infusions. An introduction and overview.
Continuous intrathecal baclofen infusion (CIBI) is a relatively new treatment modality for severe spasticity of spinal cord origin. Literature review suggests relief of severe spasms and rigidity is proven with CIBI, in patients with spinal cord injury and multiple sclerosis, while ongoing research exists for patients with acquired brain injury and cerebral palsy. Criteria for patient selection, the screening trial process, an outline of the surgical procedure, and generalities of maintenance therapies, will be reviewed broadly as per literature, as well as specifically to the Vancouver experience with adults. Additionally, reported patient outcomes and implications for nursing will be shared.
Kamensek
J
J
Vancouver General Hospital, B.C.
D000328:Adult; D001418:Baclofen / Q000008:administration & dosage*; D016903:Drug Monitoring / Q000379:methods / Q000451:nursing; D006801:Humans; D007263:Infusions, Parenteral; D007278:Injections, Spinal; D009103:Multiple Sclerosis / Q000150:complications*; D009125:Muscle Relaxants, Central / Q000008:administration & dosage*; D009128:Muscle Spasticity / Q000188:drug therapy* / Q000209:etiology* / Q000451:nursing / Q000503:physiopathology; D009730:Nursing Assessment / Q000379:methods; D018579:Patient Selection; D013119:Spinal Cord Injuries / Q000150:complications*; D016896:Treatment Outcome
D009125:Muscle Relaxants, Central; D001418:Baclofen